Visit Catalent at ICSE, Stand 8B22
Feria de Madrid, Spain
13th-15th October 2009
Learn more about our technologies and services through four live presentations
from Catalent experts at Speaker's Corner, Stand 8H42.
from Catalent experts at Speaker's Corner, Stand 8H42.
Tuesday, 13th October, 3.00pm
Growth of outsourcing opportunities and technical challenges
for biologicals in pre-filled syringes
This presentation will put in parallel the huge growth of the biotech pipeline
with the outsourcing opportunities for biologics in pre-filled syringes. It will
review the technical challenges of biotech compounds formulated
in pre-filled syringes, such as primary components selection,
compatibility, sterility, cold chain management and filling
pump technology.
with the outsourcing opportunities for biologics in pre-filled syringes. It will
review the technical challenges of biotech compounds formulated
in pre-filled syringes, such as primary components selection,
compatibility, sterility, cold chain management and filling
pump technology.
Presented by Jerôme Detreille, Director,
Sterile Technologies, Europe
Sterile Technologies, Europe
Wednesday, 14th October, 3.30pm
Poorly soluble drugs: Softgel lipid based
formulations to maximise oral absorption
The prevalence of poorly water soluble drug candidates has
led to an increasing interest for lipid based formulations, which
has demonstrated their performance to enhance the bioavailability
of BCS Class II and IV drugs. Catalent will describe the mechanistic
rationale, which underpins the use of lipid-based delivery systems
to enhance PWS drug absorption and will present the range of applications.
The second part of this presentation will focus on Catalent's approach to
development, which can efficiently and quickly turn lipid based formulations
into a final dosage form based on Catalent's softgel and Vegicaps® Soft technologies.
led to an increasing interest for lipid based formulations, which
has demonstrated their performance to enhance the bioavailability
of BCS Class II and IV drugs. Catalent will describe the mechanistic
rationale, which underpins the use of lipid-based delivery systems
to enhance PWS drug absorption and will present the range of applications.
The second part of this presentation will focus on Catalent's approach to
development, which can efficiently and quickly turn lipid based formulations
into a final dosage form based on Catalent's softgel and Vegicaps® Soft technologies.
Presented by Bruno Cuiné, Sales and Business Development Manager,
Pharmaceutical Softgel, Europe
Pharmaceutical Softgel, Europe
Thursday, 15th October, 11.30am
Packaging outsourcing: Supporting the supply chain throughout the product lifecycle
This overview of the benefits of outsourced packaging will use case studies to demonstrate how segments
of the health care market are obtaining an advantage over their peers, including start-up companies,
large pharma with new product launches and virtual companies managing product acquisitions.
of the health care market are obtaining an advantage over their peers, including start-up companies,
large pharma with new product launches and virtual companies managing product acquisitions.
Presented by Gareth Lewis, Director, Packaging Services, Europe
Thursday, 15th October, 12.00pm
The impact of recent FDA guidance on ODT Technologies: A Zydis® technology perspective
The 2008 FDA Guidance for Industry on Orally Disintegrating Tablets provides recommendations that
clarify the expectations of the ODT dosage form. The Zydis® lyophilization technology provided the
first US approved ODT in 1996; here we will present the Zydis® technology perspective on how this guidance
may have an impact on the industry.
clarify the expectations of the ODT dosage form. The Zydis® lyophilization technology provided the
first US approved ODT in 1996; here we will present the Zydis® technology perspective on how this guidance
may have an impact on the industry.
Presented by Michele Stokes, Director Business Development, Zydis® Technology
You are invited to join us in celebrating 75 years of softgel expertise at the Catalent stand on
Wednesday 14 October, 4.00pm, where we will be serving drinks and canapés.
If you would like to pre-arrange a meeting with us, please email eumarketing@catalent.com.
Catalent Pharma Solutions offers a full spectrum of services to support pharmaceutical
product development, drug delivery, manufacturing and packaging.
We have the expertise and global resources to accelerate your product's
speed to market-with unmatched service and support.
Catalent is well positioned to serve you wherever you do business.
Contact us today.
Tel: +1 866 720 3148